U.S. Pharmacist Weekly News

December 19, 2024

Telemedicine Prescribing of Controlled Substances Continued Another Year

Special dispensation was given during the COVID-19 pandemic for some controlled substances to be prescribed with only telemedicine visits. That has been extended through 2025 by the Drug Enforcement Agency and the Department of Health and Human Services as the agencies seek to make some of the leniencies permanent. This temporary extension is designed to ensure a smooth transition for patients and practitioners. Read more.

Reports of Statin-Associated Diabetes More Common in Women

Concerns about the role statins play in the development of diabetes mellitus have been increasing, but it was unclear who was most affected. A new review of FDA adverse event reporting published in BMJ Open Diabetes Research & Care now suggests that statin-related diabetes is more common in women and that the greatest number of complaints are with atorvastatin. Read more.

Pharmacists’ Role in Combatting Opioid Misuse

A new study published in Addiction Science & Clinical Practice suggests that pharmacists are in a unique position to make a difference with the opioid-related overdose epidemic in the United States. But who is most interested in taking part? Find out the results of the survey and how much difference opioid-related training can make.

Behavior of LTC Residents Dosed With Antipsychotics

The problem with off-label use of antipsychotic medications is not just that they can cause intolerable side effects, which can include tremors, restlessness, rigidity, painful muscle contractions, and the inability to stand and walk, according to a new study. Find out how researchers determined that the drugs often have the opposite effect and worsen behavior in long-term care (LTC) residents who are prescribed them.